UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM 10-Q

þ  Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2008





 ̈  Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934





Commission File Number 000-51590

ENABLE IPC CORPORATION

(Exact name of registrant as specified in its charter)

Delaware
    (State or other jurisdiction of
    incorporation or organization)38-3718471
    (I.R.S. Employer Identification Number)


29033 Avenue Sherman, Unit 202

Valencia, California 91355

(Address of principal executive offices)



661-775-9273

(Registrants telephone number, including area coder)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirement for the past 90 days.  Yes þ   No  ̈

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filed, or a smaller reporting company.  See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ̈

Accelerated filer  ̈

Non-accelerated filer    ̈  (Do not check if a smaller reporting company)

Smaller reporting company þ

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12(b)-2 of the Exchange Act) Yes  ̈   No þ

At November 10, 2008, the registrant had outstanding 37,618,400 shares of common stock, $0.001 par value per share.









ENABLE IPC CORPORATION

TABLE OF CONTENTS



Page

PART I  FINANCIAL INFORMATION

3

Item 1.

Financial Statements

3

Condensed Balance Sheets
as of September 30, 2008 (Unaudited) and March 31, 2008

3

Condensed Statements of Operations (Unaudited) 
for the six months ended September 30, 2008 and September 30, 2007,

and the period from March 17, 2005 (Inception) through September 30, 2008.

4

Condensed Statement of Stockholders' Deficit (Unaudited) 
for the period from March 17, 2005 (Inception) through September 30, 2008

5

Condensed Statements of Cash Flows (Unaudited) 
for the six months ended September 30, 2008 and September 30, 2007, 
and the period from March 17, 2005 (Inception) through September 30, 2008

6

Notes to Condensed Financial Statements (Unaudited)

8

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

13

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

19

Item 4T.

Controls and Procedures

19

PART II  OTHER INFORMATION

22

Item 1.

Legal Proceedings

20

Item 1A.

Risk Factors

20

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

28

Item 3.

Defaults Upon Senior Securities

28

Item 4.

Submission of Matters to a Vote of Security Holders

28

Item 5.

Other Information

29

Item 6.

Exhibits

29

SIGNATURES

30















PART 1 -- FINANCIAL INFORMATION

ITEM 1.

Financial Statements

ENABLE IPC CORPORATION

(A DEVELOPMENT STAGE COMPANY)

CONDENSED BALANCE SHEETS



ASSETSSeptember 30, 2008March 31, 2008(Unaudited)Current assetsCash$                    1,690$          40,171Prepaid expenses due within 12 months7,09828,760Total current assets8,78868,931Fixed assets, net10,08811,283Other assetsOther prepaid expenses4,000-Intangible assets, net715,696735,064Total other assets719,696735,064Total assets$                738,572$        815,278LIABILITIES AND STOCKHOLDERS' DEFICITCurrent liabilitiesAccounts payable$                125,536$          22,626Accrued expenses and other current liabilities197,727177,470Other liability25,00025,000Due to stockholders, net of discounts414,059477,081Total current liabilities762,322702,177Long-term liabilitiesDue to stockholders88,758129,929Present value of minimum royalty payments185,793177,150Total long-term liabilities274,551307,079Total liabilities1,036,0731,009,256Commitments and contingenciesStockholders' deficitPreferred stock; no par value; 10,000,000 sharesauthorized, no shares issued and outstanding--Common stock; $0.001 par value; 50,000,000 sharesauthorized, 37,618,400 shares issued and outstanding37,61828,679Additional paid-in capital2,402,6432,005,150Additional paid-in capital -- warrants88,00088,000Prepaid services in common stock(70,254)(119,082)Accumulated deficit(2,756,308)(2,196,725)Total stockholders' deficit(298,301)(193,978)Total liabilities and stockholders' deficit$        738,572$        815,278
   3     ENABLE IPC CORPORATION (A DEVELOPMENT STAGE COMPANY) CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)  Three months ended September 30,Six months ended 
September 30,March 17, 2005 (Inception)  through2008200720082007September 30, 2008Revenues$
-$
-$
-$
-$ -Operating expensesGeneral and administrative expensesLegal and professional fees65,61937,36092,22261,303484,622Wages and salaries37,50037,50075,00075,000532,407Research and development75,92630,550134,98597,588601,951Other general and administrative83,19178,477185,854134,843830,078Total general and administrative expenses262,236183,887488,061368,7342,449,058Loss from operations(262,236)(183,887)(488,061)(368,734)(2,449,058)Interest income/expense(47,222)(18,923)(71,522)(36,408)(305,747)Loss before provision for income taxes(309,548)(202,810)(559,583)(405,142)(2,754,805)Provision for income taxes----(1,503)Net loss$
(307,392)$ (202,810)$ (559,583)$ (405,142)$ (2,756,308)Basic and diluted loss per common share$
(0.01)$  (0.01)$ (0.02)$ (0.02)$ (0.16)Basic and diluted weighted averagecommon shares outstanding34,822,05121,182,75632,836,65518,884,64517,287,823  See Accompanying Notes to Financial Statements  4     ENABLE IPC CORPORATION (A DEVELOPMENT STAGE COMPANY) STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED)  Common StockAdditional Paid-In CapitalPrepaid Services Paid in Common StockAccumulated DeficitStockholders DeficitSharesAmountBalance at March 31, 200828,678,996$28,679$2,093,150$(119,082)$(2,196,725)(193,978)Common stock issued for cash5,371,0005,371181,629-187,000Common stock issued for services217,50021816,382-16,600Common stock issued for prepaid services317,50031819,482(19,800)-Common stock issued in satisfaction of due to stockholders3,033,4043,033179,999-183,032Amortization of prepaid services---68,62868,628Net loss----(559,583)(559,583)Balance at September 30, 200837,618,400$37,618$2,490,643$(70,254)$(2,756,308)$(298,301)
  See Accompanying Notes to Financial Statements  5     ENABLE IPC CORPORATION(A DEVELOPMENT STAGE COMPANY)CONDENSED STATEMENTS OF CASH FLOWS(UNAUDITED)Six months ended September 30, 2008Six months ended September 30, 2007March 17, 2005 (Inception) through September 30, 2008Cash flows from operating activities:Net loss$     (559,583)$    (405,142)$  (2,756,308)Adjustments to reconcile net loss to net cashprovided by operating activities:Depreciation and amortization20,56316,811124,839Accretion of due to stockholder discount46,401-68,671Stock based compensation85,228118,035422,825Stock based compensation related to office supplies--2,608Interest accrued on PV of minimum royalty payments8,64334,159207,438Changes in operating assets and liabilities:-Prepaid expenses17,662(13,981)(11,098)Other receivable-240-Accounts payable102,910-139,468Accrued liabilities20,25734,500301,164Net cash used by operating activities(257,919)(215,378)(1,500,394)Cash flows from investing activities:Purchase of intangible asset--(37,159)Purchase of fixed assets--(9,714)Net cash used by investing activities--(46,873)Cash flows from financing activities:Issuance of common stock for cash187,000181,100979,142Change in due to stockholders32,43820,257569,814Net cash provided by financing activities219,438201,3571,548,956Net change in cash(38,480)(14,021)1,690Beginning balance, April 140,17121,913-Ending balance, September 30$            1,690$             7,892$            1,690Schedule of non-cash  investing and financing activities:Issuance of 2,780,200 shares for fixed assets$                     -$                   -$          13,901(Continued)
  6     ENABLE IPC CORPORATION
    (A DEVELOPMENT STAGE COMPANY)
    CONDENSED STATEMENTS OF CASH FLOWS
    (UNAUDITED)(Continued)Six months ended September 30, 2008Six months ended September 30, 2007March 17, 2005 (Inception) through September 30, 2008Purchase of intangible assetsIssuance of 2,000,000 shares related to Technology and Patent assignment$                     -$                  -$        10,000Present value of minimum royalty payments related to Technology and Patent assignment--583,857Other liability for patent relating to ultracapacitor technology from University of Wisconsin (WARF)--25,000Present value of minimum royalty payments related to license from University of Wisconsin (WARF)--170,992$                     -$                  -$        789,849Issuance of common stock in satisfaction of due to stockholders$       183,032$         92,255$        255,037Amendment to Technology and Patent Assignment$                     -$                  -$        686,494Issuance of common stock for prepaid services$          19,800$                 -$          19,800Supplemental disclosure forCash paid forInterest$          31,761$           2,254$          65,481Income taxes$                     -$                  -$            1,503
  See Accompanying Notes to Financial Statements  7  ENABLE IPC CORPORATION (A DEVELOPMENT STAGE COMPANY) NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2008 (UNAUDITED)  Note 1. Description of Business and Summary of Significant Accounting Policies Basis of Presentation Enable IPC Corporation (hereinafter referred to as Enable IPC or the Company) is a development stage company incorporated on March 17, 2005 under the laws of the state of Delaware. Enable IPC is engaged in the development of new power technologies that combine thin films and nanotechnology.  Enable IPC (Intellectual Property Commercialization) plans to use these breakthroughs to manufacture microbatteries on microscopically thin film (which are expected to be smaller, cheaper, last longer, and be more environmentally friendly than today's standard batteries) and ultracapacitors on standard carbon sheets impregnated with nanoparticles. The accompanying unaudited condensed financial statements have been prepared in accordance with Securities and Exchange Commission requirements for interim financial statements. Therefore, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The financial statements should be read in conjunction with the Companys Annual Report on Form 10-KSB for the year ended March 31, 2008, on file with the Securities and Exchange Commission. The interim financial statements present the condensed balance sheet, statements of operations, stockholders deficit and cash flows of the Company. The financial statements have been prepared in accordance with accounting principles generally accepted in the United States. The interim financial information is unaudited. In the opinion of management, all adjustments necessary to present fairly the financial position of the Company as of September 30, 2008 and the results of operations and cash flows presented herein have been included in the financial statements. Interim results are not necessarily indicative of results of operations for the full year. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Reclassifications.  Certain reclassifications have been made to the 2007 financial statement amounts to conform to the 2008 financial statement presentation. New Accounting Pronouncements  In May 2008, the FASB issued STAFF POSITION (FSP) No. APB 14-1, "Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement)". This FSP applies to convertible debt instruments that, by their stated terms, may be settled in cash (or other assets) upon conversion, including partial cash settlement, unless the embedded conversion option is required to be separately accounted for as a derivative under FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities. FSP No. 14-1 clarifies that convertible debt instruments that may be settled in cash upon conversion (including partial cash settlement) are not addressed by paragraph 12 of APB Opinion No. 14, Accounting for Convertible Debt and Debt Issued with Stock Purchase Warrants. Additionally, this FSP specifies that issuers of such instruments should separately account for the liability and equity components in a manner that will reflect the entity's nonconvertible debt borrowing rate when interest cost is recognized in subsequent periods. The FSP is effective for financial statements issued for fiscal years beginning after December 15, 2008, and interim periods within those fiscal years. The Company does not currently have any debt instruments for which this FSP would apply and does not expect to have any significant financial impact upon its adoption in April 2009. Early adoption is not permitted. In March 2008, the FASB issued SFAS No. 161, "Disclosures about Derivative Instruments and Hedging Activities  an amendment of FASB Statement No. 133." This statement is intended to enhance the current disclosure framework in SFAS No. 133. Under SFAS No. 161, entities will have to provide disclosures about (a) how and why an entity uses derivative instruments, (b) how derivative instruments and related hedged items are accounted for under SFAS No. 133 and its related interpretations, and (c), how derivative instruments and related hedged items effect an entity's financial position, financial performance and cash flows. SFAS No. 161 is effective for all financial statements issued for fiscal and interim periods beginning after November 15, 2008. Since the Company does not currently have any derivative instruments, nor does it engage in hedging activities, the Company expects to have no significant financial impact as a result of adoption of SFAS No. 161.  8  ENABLE IPC CORPORATION (A DEVELOPMENT STAGE COMPANY) NOTES TO CONDENSED FINANCIAL STATEMENTS SEPTEMBER 30, 2008 (UNAUDITED)   In December 2007, the FASB issued SFAS No. 141 (revised 2007), "Business Combinations" ("SFAS 141R"). SFAS 141R establishes principles and requirements for how an acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, any noncontrolling interest in the acquiree, and the goodwill acquired. SFAS 141R also establishes disclosure requirements to enable the evaluation of the nature and financial effects of the business combination. SFAS 141R is effective for the Company with respect to business combinations for which the acquisition date is on or after April 1, 2009. The Company does not currently anticipate a significant financial impact upon adoption of SFAS No. 141. In December 2007, the FASB issued SFAS No. 160, "Noncontrolling Interests in Consolidated Financial Statementsan amendment of ARB No. 51" ("SFAS 160"). SFAS 160 establishes accounting and reporting standards for ownership interests in subsidiaries held by parties other than the parent, the amount of consolidated net income attributable to the parent and to the noncontrolling interest, changes in a parent's ownership interest, and the valuation of retained noncontrolling equity investments when a subsidiary is deconsolidated. SFAS 160 also establishes disclosure requirements that clearly identify and distinguish between the interests of the parent and the interests of noncontrolling owners. SFAS 160 is effective for the Company as of April 1, 2009. The Company is currently evaluating the potential impact, if any, of the adoption of SFAS 160 on the consolidated financial position, results of operations, and disclosures. Note 2. Stock-Based Compensation On April 1, 2006, the Company adopted Statement of Financial Accounting Standards (SFAS) No. 123 (revised 2004), Share-Based Payment, requiring the Company to recognize expense related to the fair value of its employee stock option awards. The Company recognizes the cost of all share-based awards on a graded vesting basis over the vesting period of the award. The Company has granted no warrants or options to employees since inception. Accordingly, the adoption of SFAS No. 123 (R) did not impact the financial statements. Note 3. Related-Party Transactions At September 30, 2008, the Company recorded owing $500,751 to related parties - $411,993 payable within 12 months and $88,758 recorded under long term liabilities.  Of the total amount, $310,028 was owed for services rendered to the Company and $190,723 was recorded for outstanding loans to the Company.  Both are summarized below. Services At September 30, 2008, the Company owed $310,028 to stockholders for services to the Company.  Of this amount, $292,723 was owed to four stockholders for consulting services rendered to the Company.  These services consisted primarily of conducting and managing research and development of the Companys microbattery technology at the University of Idaho and the Companys ultracapacitor coating method at the University of Wisconsin.  In addition, the Company owed a total of $17,305 to Board members for services rendered.  9    Loans The Company had two outstanding loans payable to stockholders on September 30, 2008.  They are summarized as follows: The first loan was for $40,000 at 13% interest per annum for a term of 24 months.  The lender also received warrants to purchase 1,000,000 restricted shares of common stock.  Proceeds of $40,000 were allocated to the warrants based on their estimated fair value (utilizing the Black-Scholes method) and credited to additional paid-in capital.  This amount is reflected as a discount against the notes payable and will be amortized to interest expense over the life of the note.  The Company is required to make monthly payments of $1,905 for 24 months.  Interest on this loan totals $5,721.  As of September 30, 2008, the Company had made twelve payments on this loan totaling $22,861 ($18,671 toward principal and $4,190 toward interest).  Total principal remaining on this loan on September 30, 2008 was $21,329.  Total unamortized discount also totaled $21,329. The second loan was for $240,000 at 13% interest per annum for a term of 30 months.  The Company is required to make monthly payments of $9,413 for 30 months.  Interest on this loan totals $42,395.  As of September 30, 2008, the Company had made seven payments on this loan totaling $65,892 ($49,270 toward principal and $16,622 toward interest).  The total principal remaining on this loan on September 30, 2008 was $190,730. A third loan was for $50,000 at 13% interest per annum for a term of 24 months.  The lender also received warrants to purchase 1,250,000 restricted shares of common stock.  Proceeds of $50,000 were allocated to the warrants based on their estimated fair value (utilizing the Black-Scholes method) and credited to additional paid-in capital.  This amount was reflected as a discount against the notes payable and will be amortized to interest expense over the life of the note.  The Company was required to make monthly payments of $2,377 for 24 months.  Interest on this loan totaled $7,050.  During August 2008, the Company issued 768,000 shares of its common stock to pay off the balance of the loan, which at the time was $30,725.  The remaining unamortized discount of $30,725 was expensed at the time of the conversion to interest expense. Note 4. Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.  The Company is in the development stage, has no operating revenue and incurred a net loss of approximately $2,756,308 for the period from March 17, 2005 (Date of Inception) through September 30, 2008.  The Companys management is in the process of raising additional capital for the Company. As part of this effort, during the fiscal year ending March 31, 2006, the Company issued an aggregate of 2,807,000 shares of common stock for proceeds of $268,400.  Also, in September 2005, the Company issued to another private investor a warrant to purchase 305,000 shares of common stock at an exercise price of $0.10 per share, none of which had been exercised as of September 30, 2008. During the fiscal year ended March 31, 2007, the Company issued an aggregate of 3,017,497 shares of common stock for cash proceeds of $202,225, less $3,302 in offering costs.  In addition, the Company issued an aggregate of 150,000 shares of common stock for services valued at $10,500, 100,000 shares to satisfy loans from stockholders totaling $7,000, warrants to purchase an aggregate of 250,000 shares of common stock at an exercise price of $0.01 per share, all of which had been exercised as of September 30, 2008 for total proceeds of $2,500, and warrants to purchase an aggregate of 100,000 shares of common stock at an exercise price of $0.10 per share, none of which have been exercised as of September 30, 2008. During the fiscal year ended March 31, 2008, the Company issued an aggregate of 9,142,500 shares of common stock to 18 investors for proceeds of $309,000, less $3,413 in offering costs.  In addition, the Company issued an aggregate of 3,599,641 shares to 16 investors for services relating to research and development, legal and business consulting activities valued at $409,325.  In addition, the Company issued an aggregate of 1,500,000 shares, to five investors for prepaid services relating to business and research and development consulting, valued at $145,000, which shares are amortized over the performance period, and an aggregate of  714,358 shares to satisfy outstanding loans from stockholders totaling $65,005, reacquired an aggregate of 1,500,000 shares from an investor and issued warrants to purchase up to 2,250,000 shares of common stock at an exercise price of $0.04 per share, 50,000 of which had been exercised as of September 30, 2008 for proceeds of $2,000.  10     During April 2008, the Company issued an aggregate of 1,000,000 shares of common stock to a stockholder as partial compensation for services relating to microbattery research and development consulting activities accrued since 2005 and valued at $100,000.  Also during April 2008, the Company issued 100,000 shares in prepaid services relating to research and development activities valued at $9,000, which will be amortized over the performance period. During May 2008, the Company issued an aggregate of 1,250,000 shares of common stock to an investor for proceeds of $50,000.  Also during May 2008, the Company issued an aggregate of 145,000 shares of common stock to an investor for business consulting services valued at $13,000.  The Company also issued 72,500 shares of common stock to an investor for business services valued at $3,600 and 217,500 shares of common stock for prepaid business services valued at $10,800, which will be amortized over the performance period. During June 2008, the Company issued an aggregate of 1,040,000 shares of common stock to five investors for proceeds of $26,000.  Also during June 2008, the Company issued 200,000 shares of common stock to a stockholder for accrued business consulting services valued at $12,000. During August 2008, the Company issued an aggregate of 2,620,000 shares of common stock to seven investors for net proceeds of $111,000. Also during August, the Company issued 768,000 shares to an investor to satisfy a loan obligation totaling $30,725.  In addition, during August 2008 the Company issued an aggregate of 1,526,404 shares to four investors for services rendered; 1,065,404 of these were issued to three investors for accrued research and development services totaling $40,307 relating to the Companys ultracapacitor technology and the remaining 461,000 shares were issued for commissions on investments received and recorded as offering costs net of the investments received. The Company continues to seek to raise additional funds to support operations through private placements of equity and debt securities. Management believes that the funds raised through this plan will be sufficient to support operations through the year ending March 31, 2009. These conditions give rise to substantial doubt about the Companys ability to continue as a going concern. These financial statements do not include adjustments relating to the recoverability and classification of reported asset amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Companys continuation as a going concern is dependent upon its ability to obtain additional financing from the sale of its common stock, as may be required, and ultimately, to attain profitability. Note 5. Present Value of Minimum Royalty Payments, Net The Company has entered into an Exclusive License Agreement (License Agreement) granting the Company proprietary rights from the owner of the technology, the Wisconsin Alumni Research Foundation (WARF), in consideration for an initial license fee of $50,000, reimbursement of WARFs patent costs ($12,971) and annual royalties equal to 5% of the net sales of the product or $25,000, whichever is greater, beginning in calendar year 2010. The Company recorded the present value of the above royalty payments totaling $170,955 (assuming a 10% per annum imputed interest rate) as part of the value of the intangible asset. As of September 30, 2008, the present value of minimum royalty payments, net is as follows:  11    Present value of minimum royalty payments $ 170,955 Plus:  accrued interest on minimum royalty payments 14,838 Present value of minimum royalty payments, net $ 185,973  
                                                                                                          ============= Note 6. Common Stock During April 2008, the Company issued an aggregate of 1,000,000 shares of common stock to a stockholder as partial compensation for services relating to microbattery research and development consulting activities accrued since 2005 and valued at $100,000.  Also during April 2008, the Company issued 100,000 shares in prepaid services relating to research and development activities valued at $9,000, which will be amortized over the performance period. During May 2008, the Company issued an aggregate of 1,250,000 shares of common stock to an investor for proceeds of $50,000.  Also during May 2008, the Company issued an aggregate of 145,000 shares of common stock  to an investor for business consulting services valued at $13,000.  The Company also issued 72,500 shares of common stock to an investor for business services valued at $3,600 and 217,500 shares of common stock for prepaid business services valued at $10,800, which will be amortized over the performance period. During June 2008, the Company issued an aggregate of 1,040,000 shares of common stock to five investors for proceeds of $26,000.  Also during June 2008, the Company issued an aggregate of 200,000 shares of common stock to a stockholder for accrued business consulting services valued at $12,000. During August 2008, the Company issued an aggregate of 2,620,000 shares of common stock to seven investors for net proceeds of $111,000. Also during August, the Company issued 768,000 shares to an investor to satisfy a loan obligation totaling $30,725.  In addition, during August 2008 the Company issued an aggregate of 1,526,404 shares to four investors for services rendered; 1,065,404 of these were issued to three investors for accrued research and development services totaling $40,307 relating to the Companys ultracapacitor technology and the remaining 461,000 shares were issued for commissions on investments received and recorded as offering costs net of the investments received. Note 7.  Partnership Agreement and Initial Contract In July 2008, we announced a partnership agreement with IMDEA Energy Institute in Madrid, Spain, which marked the first commercial sale of our ultracapacitor product.  The agreement calls for the delivery of a number of electrodes  a key ultracapacitor component  for specialized applications.   Proceeds from this agreement, which are scheduled to be invoiced in the next quarter, amount to 47,000 Euros (about $59,000). Note 8. Subsequent Events On October 1, 2008, we announced that we had entered into an LLC Membership Purchase Agreement with SolRayo, LLC, a Wisconsin limited liability company (SolRayo) for the purchase of Class A Membership Interests in SolRayo equal to 50.01% of SolRayos total outstanding membership interests.  Prior to entering into the Agreement, we were a party, with SolRayo, to a Joint Development Agreement, dated March 29, 2007, pursuant to which we provided cash and stock payments to support the development of certain ultracapacitor technology licensed by us from the University of Wisconsin through its Wisconsin Alumni Research Fund.  We provided funding to SolRayo of an aggregate of $87,340 before the termination of the Joint Development Agreement in January 2008.  In consideration for the issuance and sale of the Class A Membership Interests, we have agreed to provide to SolRayo in kind contributions with an aggregate value of $250,000, pursuant to the terms and conditions of a $250,000 clean energy grant received by SolRayo from the Wisconsin Energy Independence Fund.  This grant will be used by SolRayo to defray development costs and to support further research and development leading to the use of the ultracapacitor in new clean energy technologies. In November 2008, we invoiced IMDEA Energy Institute for the first portion of our agreement, amounting to 23500 Euros.  This invoice marks our first commercial sale.  The agreement calls for the delivery of a number of electrodes for specialized applications.  12   ITEM 2. Managements Discussion and Analysis of Financial Condition and Results of Operations. This quarterly report contains forward-looking statements including statements regarding our expectations, beliefs, intentions or future strategies that are signified by the words "expects," "anticipates," "intends," "believes" or similar language. These forward-looking statements involve risks, uncertainties and other factors. All forward-looking statements included in this quarterly report are based on information available to us on the date hereof and speak only as of the date hereof. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise. The factors discussed below under "Risk Factors" and elsewhere in this quarterly report are among those factors that in some cases have affected our results and could cause the actual results to differ materially from those projected in the forward-looking statements. In this quarterly report, the "Company," "we," "us" and "our" refer to Enable IPC Corporation, a Delaware corporation. Overview/Recent Developments This discussion is intended to supplement, and should be read in conjunction with, our financial statements and the accompanying notes to the financial statements. We were incorporated in March 2005 to develop and commercialize rechargeable batteries for use in low power applications.  One of our products will be a thin film lithium battery. A patent application covering this technology was assigned to us in March 2005 by Dr. Sung H. Choi, our Technical Advisor and a principal stockholder. This product is in the very earliest stage of development. In addition, we have entered into an Exclusive License Agreement (License) with the Wisconsin Alumni Research Foundation (the licensing arm of the University of Wisconsin) which will allow us to eventually fully commercialize and sell an ultracapacitor technology. We believe this technology will allow us and our customers to make ultracapacitors which will compliment our microbattery as well as meet performance specifications for existing consumer, industrial and possibly transportation products.  In July 2008 we announced a partnership agreement with IMDEA Energy Institute in Madrid, Spain, which marked the first commercial sale of our ultracapacitor product.  The agreement calls for the delivery of a number of electrodes  a key ultracapacitor component  for specialized applications. To date, we have commenced limited business operations and have realized no income. We have funded our operations through private placements of equity and loans and contributions from our founders. We have incurred a net loss from operations from inception through September 30, 2008, of $2,756,308. On October 1, 2008, we announced that we had entered into an LLC Membership Purchase Agreement with SolRayo, LLC, a Wisconsin limited liability company (SolRayo), for the purchase of Class A Membership Interests in SolRayo equal to 50.01% of SolRayos total outstanding membership interests.  Prior to entering into the Agreement, we were a party, with SolRayo, to a Joint Development Agreement, dated March 29, 2007, pursuant to which we provided cash and stock payments to support the development of certain ultracapacitor technology licensed by us from the University of Wisconsin through its Wisconsin Alumni Research Fund.  We provided funding to SolRayo of an aggregate of $87,340 before the termination of the Joint Development Agreement in January 2008.  In consideration for the issuance and sale of the Class A Membership Interests, we have agreed to provide to SolRayo in kind contributions with an aggregate value of $250,000, pursuant to the terms and conditions of a $250,000 clean energy grant received by SolRayo from the Wisconsin Energy Independence Fund.  This grant will be used by SolRayo to defray development costs and to support further research and development leading to the use of the ultracapacitor in new clean energy technologies. Results of Operations Three months ended September 30, 2008 compared to three months ended September 30, 2007 Revenues.   We did not generate any revenue in the three months ended September 30, 2008, as our focus since inception has been on raising funds to conduct the research and development of our technology. We also generated no revenue during the three-month period ended September 30, 2007. We are a development stage company in our third year of research and development activities, and do not anticipate receiving revenue until we complete product development. There can be no assurance that we will ever receive revenues or reach profitability.  13   General and Administrative Expenses.  General and administrative expenses for the three months ended September 30, 2008 were $262,236, higher than the $183,887 in general and administrative expenses during the same period in 2007.  These expenses for the three months ended September 30, 2008 included $37,500 in wages and salaries to our sole employee, which equaled the wage expenses for the comparable period in 2007. In the three months ended September 30, 2008, we incurred $65,619 in legal and accounting expenses, compared with $37,360 in such expenses for the same period in 2007.  These 2008 expenses included $4,500 in auditor fees, less than the $7,400 expense for the same period in 2007; $10,661 in investor relations and EDGAR filing activities and fees, an increase from $7,417 for the same period in 2007 due to increased investor relations activities, and $50,458 in legal fees, a significant increase from $22,543 for the same period in 2007 due primarily to the timing of invoicing for services rendered for multiple public company filings. We had $75,926 in research and development expenses for the three months ended September 30, 2008, a large increase from $30,550 for the three months ended September 30, 2007.  This increase was due to additional testing and packaging costs incurred in connection with both our microbattery and ultracapacitor technologies. We incurred $83,191 in other expenses during the three months ended September 30, 2008, a slight increase from the $78,477 in other expenses we incurred for the three months ended September 30, 2007. The 2008 expenses consisted of $32,114 for consulting expenses, a slight decrease from $37,875 for the same period in 2007; $11,980 for public relations activities, an expense we did not incur during the same period in 2007 due to the hiring of our new public relations firm; $8,757 in depreciation and amortization, a slight increase from $8,414 for the same period in 2007; $5,500 in Board member services, an increase from $4,000 for the same period in 2007; $5,760 in rent, a decrease from $9,524 for the same period in 2007 due primarily to the savings on rent by our move to our new facility in June 2008; $7,650 in expenses relating to the annual meeting of shareholders, an increase from $4,682 for the same period in 2007 reflecting increased annual meeting costs; $3,620 in travel, conferences and related activities, an increase from $2,668 for the same period in 2007, due to an increase in travel related to research and development on the ultracapacitor and microbattery technologies; and $7,810 in other expenses, a decrease from $11,314 during the same period in 2007.  We anticipate that as we ramp up our operations (including the continuing obligations of a public company),our general and administrative expenses will increase significantly. Sales and Marketing Expenses.  We did not incur sales and marketing expenses for the three months ended September 30, 2008, but intend to develop our sales and marketing efforts at a measured pace until our products are ready for introduction into the market. We also incurred no sales and marketing expenses for the three months ended September 30, 2007. Interest Expense   We had interest expense of $47,222 for the three months ended September 30, 2008, compared to interest expense of $19,731 for the comparable period in 2007.  The increase was partially attributable to the elimination of the interest accumulation on the microbattery payments.  In addition, during the three months ended September 30, 2008, we issued 768,000 shares to an existing shareholder to retire a loan to that shareholder.  The remaining unamortized discount of $30,725 was expensed at the time of the conversion. Net Loss.  As a result of the foregoing factors, our net loss was $309,458 or $0.01 per share, for the three months ended September 30, 2008. This loss is greater than the net loss of $202,810, or $0.01 per share, for the three months ended September 30, 2007. Six months ended September 30, 2008 compared to six months ended September 30, 2007 Revenues.   We did not generate any revenue in the six months ended September 30, 2008, as our focus since inception has been on raising funds to conduct the research and development of our technology. We also generated no revenue during the six-month period ended September 30, 2007. We are a development stage company in our third year of research and development activities, and do not anticipate receiving revenue until we complete product development. There can be no assurance that we will ever receive revenues or reach profitability.  14    General and Administrative Expenses.  General and administrative expenses for the six months ended September 30, 2008 were $488,061, higher than the $368,734 in general and administrative expenses during the same period in 2007.  These expenses for the six months ended September 30, 2008 included $75,000 in wages and salaries to our sole employee, which equaled the wage expenses for the comparable period in 2007. In the six months ended September 30, 2008, we incurred $92,222 in legal and accounting expenses, compared with $61,303 in such expenses for the same period in 2007.  These 2008 expenses included $18,500 in auditor fees, an increase over the $12,400 expense for the same period in 2007, due to an increased workload for the auditors resulting from our growth in fiscal 2008.  The legal and accounting expenses for the six months ended September 30, 2008 also included $19,093 in investor relations and EDGAR filing fees and other related activities, an increase from $16,836 for the same period in 2007 due to increased investor relations activities; and $54,629 in legal fees, an increase from $32,067 for the same period in 2007 due to increased legal fees associated with being a public company and legal expenses related to our microbattery patent application. We had $134,985 in research and development expenses for the six months ended September 30, 2008, an increase from $97,588 for the six months ended September 30, 2007.  This increase was due to additional testing and packaging costs incurred in connection with the microbattery and ultracapacitor technologies. We incurred $185,854 in other expenses during the six months ended September 30, 2008, an increase from the $134,843 in other expenses we incurred for the six months ended September 30, 2007. The 2008 expenses consisted of $76,228 for consulting expenses, a large increase from $44,450 for the same period in 2007, due to the addition of certain consultants and an overall increase in the activities of our consultants; $30,950 for public relations activities, an expense we did not incur during the same period in 2007 due to the hiring of our new public relations firm; $20,563 in depreciation and amortization, an increase from $16,811 for the same period in 2007; $10,000 in Board member services, an increase from $8,000 for the same period in 2007; $17,612 in rent, a decrease from $19,048 for the same period in 2007 due primarily to the rent savings on our new facility; $7,650 in expenses relating to the annual meeting of shareholders, an increase from $4,682 for the same period in 2007 reflecting increased annual meeting costs;  $5,447 in travel, conferences and related activities, a large decrease from $11,028 for the same period in 2007, due to a decrease in travel related to conferences and our microbattery and ultracapacitor technologies; $5,351 in insurance, a decrease from the $7,025 for the same period in 2007 reflecting slightly lower liability insurance premiums; $4,964 in telephone and utilities expense, an increase from $3,416 for the same period in 2007 due to increased related fees; and $7,089 in other expenses, a large decrease from $20,383 during the same period in 2007 due mostly to some extraordinary 2007 expenses for website development and brochure design and printing amounting to $15,397.  We anticipate that as we ramp up our operations (including the continuing obligations of a public company), our general and administrative expenses will increase significantly. Sales and Marketing Expenses.  We did not incur sales and marketing expenses for the six months ended September 30, 2008, but intend to develop our sales and marketing efforts at a measured pace until our products are ready for introduction into the market. We also incurred no sales and marketing expenses for the six months ended September 30, 2007. Interest Expense.   We had interest expense of $71,522 for the six months ended September 30, 2008, compared to interest expense of $36,408 for the comparable period in 2007.  The increase was partially attributable to interest on additional loans from stockholders.  In addition, during the six months ended September 30, 2008, we issued 768,000 shares to an existing shareholder to retire a loan to that shareholder.  The remaining unamortized discount of $30,725 was expensed at the time of the conversion. Net Loss.  As a result of the foregoing factors, our net loss was $559,583 or $0.02 per share, for the six months ended September 30, 2008. This loss is greater than the net loss of $405,142, or $0.02 per share, for the six months ended September 30, 2007. Liquidity and Capital Resources From our date of inception (March 17, 2005), we have obtained the majority of our cash resources from private placements of equity and loans and contributions from our founders. Our operating plan for the years ending March 31, 2009 and 2010 is focused on development of our products. We currently anticipate that cash of $1,500,000 isrequired to support this plan. At September 30, 2008, we had only $1,690 in cash, and had a burn rate of approximately $37,541 per month during the quarter. We are in the process of raising additional capital.  15      During the fiscal year ended March 31, 2006, we issued an aggregate of 2,807,000 shares of common stock for proceeds of $268,400, and issued a warrant to purchase 305,000 shares of common stock at an exercise price of $0.10 per share (such warrant had not been exercised as of September 30, 2008).  In the fiscal year ended March 31, 2007, we issued an aggregate of 3,017,497 shares of common stock for cash proceeds of $198,923.  During the fiscal year ended March 31, 2008, we issued an aggregate of 9,142,500 shares of common stock to 18 investors for proceeds of $309,000, less $3,413 in offering costs.  In addition, we issued an aggregate of 3,599,641 shares of common stock to 16 investors for services relating to research and development, legal and business consulting activities valued at a total of $409,325.  We also issued an aggregate of 1,500,000 shares, valued at $145,000, to five investors for prepaid services relating to business and research and development consulting, and which are amortized over the performance period, and an aggregate of 714,358 shares of common stock to repay loans of $65,005, reacquired 1,500,000 shares from an investor and issued warrants to purchase up to 2,250,000 shares of common stock at an exercise price of $0.04 per share, 50,000 of which had been exercised at September 30, 2008, for total proceeds of $2,000.  We have continued to raise funds during the first six months of fiscal 2009.  During April 2008, we issued an aggregate of 1,000,000 shares of common stock, valued at $100,000, to an investor as partial compensation for services relating to microbattery research and development activities accrued since 2005, and 100,000 shares of common stock, valued at $9,000, to one investor for prepaid services relating to research and development activities, which will be amortized over the performance period.  During May 2008, we issued 1,250,000 shares of common stock to an investor for proceeds of $50,000.  We also issued during that month 145,000 shares of common stock to an investor for business consulting services valued at $13,000 and 290,000 shares for prepaid services, valued at $14,400, which will be amortized over the performance period.  During June 2008, we issued an aggregate of 1,040,000 shares of common stock to five investors for proceeds of $26,000.   Also during June 2008, we issued an aggregate of 200,000 shares of common stock to a stockholder for accrued business consulting services valued at $12,000. During August 2008, we issued an aggregate of 2,620,000 shares of common stock to seven investors for net proceeds of $111,000. Also during August, we issued 768,000 shares to an investor to satisfy a loan obligation totaling $30,725.  In addition, during August 2008 we issued an aggregate of 1,526,404 shares to four investors for services rendered; 1,065,404 of these were issued to three investors for accrued research and development services totaling $40,307 relating to our ultracapacitor technology and the remaining 461,000 shares were issued for commissions on investments received and recorded as offering costs net of the investments received. On October 1, 2008, we announced that we had entered into an LLC Membership Purchase Agreement with SolRayo for the purchase of Class A Membership Interests in SolRayo equal to 50.01% of SolRayos total outstanding membership interests.   Prior to entering into the Agreement, we were a party, with SolRayo, to a Joint Development Agreement, dated March 29, 2007, pursuant to which we provided cash and stock payments to support the development of certain ultracapacitor technology licensed by us from the University of Wisconsin through its Wisconsin Alumni Research Fund.  We provided funding to SolRayo of an aggregate of $87,340 before the termination of the Joint Development Agreement in January 2008.  In consideration for the issuance and sale of the Class A Membership Interests, we have agreed to provide to SolRayo in kind contributions with an aggregate value of $250,000, pursuant to the terms and conditions of a $250,000 clean energy grant received by SolRayo from the Wisconsin Energy Independence Fund.  This grant will be used by SolRayo to defray development costs and to support further research and development leading to the use of the ultracapacitor in new clean energy technologies. We continue to seek to raise additional funds to support operations through private placements of equity and debt securities. We believe that the funds raised through our plan will be sufficient to support our operations through the year ending March 31, 2009. A large portion of our anticipated costs will relate to product research and development. In addition, we plan to invest in additional employees, and to build our infrastructure to comply with the requirements of being a publicly traded company. We currently plan to hire two full time engineers to assist with product development. Once we receive the required additional financing, we anticipate continued growth in our operations and a corresponding growth in our operating expenses and capital expenditures.   We anticipate receiving some revenue from operations in the next year, but not enough to meet our anticipated costs.  Therefore, our success will be largely dependent on funding from private placements of equity securities. There can be no assurance that we will be successful in raising any capital, and at the present time, we have no other agreements or arrangements for any private placements.  16    All of these conditions give rise to substantial doubt about our ability to continue as a going concern. Our financial statements do not include adjustments relating to the recoverability and classification of reported asset amounts or the amount and classification of liabilities that might be necessary should we be unable to continue as a going concern. Our continuation as a going concern is dependent upon our ability to obtain additional financing from the sale of our common stock, as may be required, and ultimately to attain profitability. The report of our independent certified public accountants, included in our Annual Report on Form 10-KSB for the year ended March 31, 2008, contains a paragraph regarding our ability to continue as a going concern. During the six months ended September 30, 2008, we continued to spend cash to fund our operations. Cash used by operating activities for the three months ended September 30, 2008 equaled $257,919, and consisted principally of our net loss of $559,583, plus increases in depreciation and amortization of $20,563, stock-based compensation of $85,228, interest of $8,643 accrued on the present value of the minimum royalty payments to WARF, prepaid expenses of $17,662, accounts payable of $102,910 and accrued liabilities of $20,257, and the accretion of due to stockholder discount of $46,401.  During the comparable period in 2007, net cash of $215,378 was used by operating activities, consisting of our net loss of $405,142, offset by decreases in prepaid expenses of $13,981, and increases in accrued liabilities of $34,500, interest of $34,159 accrued on the present value of our minimum royalty payments to Dr. Choi (which payments were restructured in fiscal 2008), and depreciation and amortization of $16,811, stock-based compensation of $118,035 and other receivables of $240. We did not use any cash in investing activities for the six months ended September 30, 2008 or the six months ended September 30, 2007. Cash flow from financing activities for the six months ended September 30, 2008 produced a net increase in cash of $219,438, consisting of $187,000 from the issuance of common stock for cash and an increase of $32,438 in the total amounts due to our stockholders.  During the six months ended September 30, 2007, cash flows from financing activities produced a net increase of cash of $201,357, consisting of $181,000 from the issuance of common stock and $20,257 from an increase in the amounts due to our stockholders. As of September 30, 2008, we had cash and cash equivalents amounting to $1,690, a decrease from the balance of $40,171 at March 31, 2008. Our working capital deficit increased to $753,534 at September 30, 2008, from $633,246 at March 31, 2008. There were no material commitments for capital expenditures at September 30, 2008. Our research and development activities over the next twelve months are expected to consist of the packaging of our microbattery product for certain, select low power applications, while continuing the work to optimize its power output.  This development work could take a year.  In addition, we expect to continue to optimize the ultracapacitor process for specific applications. As of September 30, 2008, we are uncertain as to the completion date of our research and development, or if products will ever be completed as a result of this research and development activity. We anticipate that the funds spent on research and development activities will need to increase prior to completion of a product. We may not be able to secure funding in the future necessary to complete our intended research and development activities. We have certain minimum annual royalty payments to the University of Wisconsins licensing arm, WARF, of $25,000 beginning in calendar year 2010. At September 30, 2008, we had no off-balance sheet arrangements.  17    Critical Accounting Policies The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires us to make judgments, assumptions and estimates that affect the amounts reported. Note 1 of Notes to Financial Statements describes the significant accounting policies used in the preparation of the financial statements. Certain of these significant accounting policies are considered to be critical accounting policies, as defined below. A critical accounting policy is defined as one that is both material to the presentation of our financial statements and requires management to make difficult, subjective or complex judgments that could have a material effect on our financial condition and results of operations. Specifically, critical accounting estimates have the following attributes: 1) we are required to make assumptions about matters that are highly uncertain at the time of the estimate, and 2) different estimates we could reasonably have used, or changes in the estimate that are reasonably likely to occur, would have a material effect on our financial condition or results of operations. Estimates and assumptions about future events and their effects cannot be determined with certainty. We base our estimates on historical experience and on various other assumptions believed to be applicable and reasonable under the circumstances. These estimates may change as new events occur, as additional information is obtained and as our operating environment changes. These changes have historically been minor and have been included in the financial statements as soon as they became known. Based on a critical assessment of our accounting policies and the underlying judgments and uncertainties affecting the application of those policies, management believes that our financial statements are fairly stated in accordance with accounting principles generally accepted in the United States, and present a meaningful presentation of our financial condition and results of operations. In preparing our financial statements to conform to accounting principles generally accepted in the United States, we make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes. These estimates include useful lives for fixed assets for depreciation calculations and assumptions for valuing options and warrants. Actual results could differ from these estimates. We consider that the following are critical accounting policies: Research and Development Expenses.  All research and development costs are expensed as incurred. The value of acquired in-process research and development is charged to expense on the date of acquisition. Research and development expenses include, but are not limited to, payroll and personnel expense, supplies, raw materials to fabricate our prototype devices, manufacturing costs, consulting, legal fees and research-related overhead. Accrued liabilities for raw materials to manufacture our prototype devices, manufacturing costs, and patent legal fees are included in accrued liabilities and included in research and development expenses. Use of Estimates.  The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates. Fixed Assets.  Fixed assets are stated at cost less accumulated depreciation. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets. The cost of repairs and maintenance is charged to expense as incurred. Expenditures for property betterments and renewals are capitalized. Upon sale or other disposition of a depreciable asset, cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in other income (expense). We periodically evaluate whether events and circumstances have occurred that may warrant revision of the estimated useful life of fixed assets or whether the remaining balance of fixed assets should be evaluated for possible impairment. We use an estimate of the related undiscounted cash flows over the remaining life of the fixed assets in measuring their recoverability.  18    Stock-based Compensation.  On April 1, 2006 we adopted Statement of Financial Accounting Standards (SFAS) No. 123 (revised 2004), Share-Based Payment, requiring us to recognize expense related to the fair value of our employee stock option awards. We recognize the cost of all share-based awards on a graded vesting basis over the vesting period of the award. We have granted no warrants or options to employees since inception. Accordingly, the adoption of SFAS No. 123 (R) did not impact our financial statements. Off-Balance Sheet Arrangements We do not have any off-balance sheet arrangements. ITEM 3.Quantitative and Qualitative Disclosures About Market Risk. Market risk generally represents the risk of loss that may result from the potential change in value of a financial instrument as a result of fluctuations in interest rates and market prices. We do not currently have any trading derivatives nor do we expect to have any in the future. We have established policies and internal processes related to the management of market risks, which we use in the normal course of our business operations.  Intangible Asset Risk  We have intangible assets and perform goodwill impairment tests annually and whenever events or circumstances indicate that the carrying value may not be recoverable from estimated future cash flows. As a result of our periodic evaluations, we may determine that the intangible asset values need to be written down to their fair values, which could result in material charges that could be adverse to our operating results and financial position. We evaluate the continuing value of goodwill by using valuation techniques based on multiples of earnings, revenue, EBITDA (i.e., earnings before interest, taxes, depreciation and amortization) particularly with regard to entities similar to us that have recently been acquired. We also consider the market value of our own stock and those of companies similar to ours. As of September 30, 2008, we believe our intangible assets are recoverable; however, changes in the economy, the business in which we operate and our own relative performance could change the assumptions used to evaluate intangible asset recoverability. We continue to monitor those assumptions and their effect on the estimated recoverability of our intangible assets.  Equity Price Risk  At September 30, 2008, we did not own any equity investments. As a result, we do not currently have any direct equity price risk.  Commodity Price Risk  We do not enter into contracts for the purchase or sale of commodities. As a result, we do not currently have any direct commodity price risk.  ITEM 4T. Controls and Procedures. Disclosure Controls and Procedures Under the supervision and with the participation of our Chief Executive Officer and Acting Chief Financial Officer, our management evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2008. Based on this evaluation, our Chief Executive Officer and Acting Chief Financial Officer concluded that our disclosure controls and procedures were effective in gathering, analyzing and disclosing information needed to satisfy our disclosure obligations under the Securities Exchange Act of 1934 (Exchange Act).   19    Changes in Internal Controls There were no changes in our internal controls or in other factors during the period covered by this quarterly report that have materially affected or are likely to materially affect our internal controls over financial reporting.  PART II -- OTHER INFORMATION ITEM 1. Legal Proceedings. Not applicable. ITEM 1A. Risk Factors Special Note About Forward-Looking Statements Some of the information in this quarterly report contains forward-looking statements that involve substantial risks and uncertainties. You can identify these statements by forward-looking words such as "may," "will," "expect," "intend," "anticipate," "believe," "estimate," and "continue" or similar words. You should read statements that contain these words carefully because they: · discuss our expectations about our future performance; · contain projections of our future operating results or of our future financial condition; or · state other "forward-looking" information. We believe it is important to communicate our expectations to our stockholders. There may be events in the future, however, that we are not able to predict accurately or over which we have no control. The risk factors listed in this section provide examples of risks, uncertainties and events that may cause our actual results to differ materially from the expectations we describe in our forward-looking statements. You should be aware that the occurrence of any of the events described in these risk factors could have a material and adverse effect on our business, results of operations and financial condition. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise. Risks Related To Our Business Our auditors have stated that they have doubts as to our ability to continue as a going concern, which could hamper our ability to obtain investment capital and prevent us from implementing our business plan. Our independent auditors, L.L. Bradford & Co., have indicated that they have substantial doubt as to our ability to continue as a going concern. This opinion is based on their analysis of our financial condition (see "Report of Independent Registered Accounting Firm" in our annual report on Form 10-KSB for the year ended March 31, 2008). This opinion could seriously hamper our ability to raise the additional funds we need to implement our business plan. If we cannot obtain additional funds, it is likely that we will be unable to implement our business plan. We are an early stage company with products currently available for commercial sale in limited applications, and have a limited operating history on which to evaluate our potential for future success. We were formed in March 2005 and have only a limited operating history upon which you can evaluate our business and prospects. We have yet to develop sufficient experience regarding actual revenues to be received from our operations. In addition, we have products currently available for commercial sale in limited application (i.e., the improvement of existing ultracapacitor electrodes), and do not to expect expand this product base in the near future. We are a start-up company. You must consider the risks and uncertainties frequently encountered by early stage companies in new and rapidly evolving markets such as competing technologies, lack of customer acceptance of a new or improved product and obsolescence of the technology before it can be fully commercialized. If we are unsuccessful in addressing these risks and uncertainties, our business, results of operations and financial condition will be materially and adversely affected.  20   We expect losses for the foreseeable future and may never achieve profitability. For the period from March 17, 2005 (date of inception) through September 30, 2008, we had net losses from operations of $2,756,308.  We will continue to incur losses from operations for the foreseeable future. These losses will result primarily from costs related to product research and development. In addition, we plan to invest in additional employees to assist with product development and to build our infrastructure to comply with the requirements of being a publicly traded company. Our management believes these expenditures are necessary to commercialize our technology and to penetrate the markets for our products. If our revenue growth is slower than anticipated or our operating expenses exceed expectations, our losses will be significantly greater. We may never achieve profitability. If we do not raise additional capital, we may have to curtail or even cease operations. Our operating plan for the years ending March 31, 2009 and 2010 is focused on development of our products. We currently anticipate that additional cash of $1,500,000 will be required to support this plan. At September 30, 2008, we had only $1,690 in cash. We are actively seeking additional funding. Obtaining capital has been and will continue to be challenging in an extremely difficult environment, due to uncertainty in the United States and global economies and current world instability. We currently have no commitments for any additional funding, and there can be no assurance that we will be able to obtain additional funding in the future from either debt or equity financings, bank loans, collaborative arrangements or other sources on terms acceptable to us, or at all. If adequate funds are not available or are not available on acceptable terms when required, we may be required to significantly curtail our operations or may not be able to fund expansion, take advantage of unanticipated acquisition opportunities, develop or enhance services or products or respond to competitive pressures. Any one of these could have a material adverse effect on our business, results of operations and financial condition. Raising additional capital may cause significant dilution to our stockholders. We are actively seeking additional funding. If we raise additional funds through the issuance of equity or convertible debt securities, the percentage ownership of our stockholders will be reduced, stockholders may experience additional dilution and such securities may have rights, preferences and privileges senior to those of our common stock. If we obtain additional funding through debt financing, we may not receive favorable terms. To obtain additional capital, we may need to use debt financing. If we are required to borrow money, we will incur interest expenses, which will negatively impact our operating results. We may also be subject to restrictive covenants in the debt agreement that will limit our operating flexibility. Establishing our revenues and achieving profitability will depend on our ability to develop and commercialize our products. Much of our ability to establish revenues and to achieve profitability and positive cash flows from operations will depend on the successful introduction of our products in development. Many products based on our technologies will represent new applications, and our prospective customers will not use our products unless they determine that the benefits provided by these products are greater than those available from competing products. We may be required to undertake time-consuming and costly development activities for new products. In addition, we may also be required to seek regulatory clearance or approval in order to commercialize new products. Although we are not currently aware of any regulatory requirements that may affect our operations, in the event that we elect to pursue alternative battery or ultracapacitor electrolyte chemistries we might be subject to state environmental laws or regulations governing the disposal of hazardous chemicals. We currently have no plans to pursue any such alternative chemistries. The completion of the development and commercialization of any of our products under development remains subject to all of the risks associated with the commercialization of new products based on innovative technologies, including unanticipated technical or other problems, manufacturing difficulties and the possible insufficiency of the funds allocated for the completion of such development.  21     Competition for experienced personnel is intense and our inability to attract and retain qualified personnel could significantly interrupt our business operations. Our future success will depend, to a significant extent, on the ability of our management to operate effectively, both individually and as a group. Given our early stage of development, we are dependent on our ability to attract, retain and motivate high caliber key personnel. Competition for qualified personnel in our industry is intense, and we may not be successful in attracting and retaining such personnel. There may be only a limited number of persons with the requisite skills to serve in these key positions. We may be unable to retain our key employees or attract, assimilate and retain other highly qualified employees in the future. Competitors and others may in the future attempt to recruit our employees. We depend on our current executive officers. Our performance is substantially dependent on the continued services and on the performance of our executive officers and other key employees and consultants, particularly David A. Walker, our Chief Executive Officer, and Mark A. Daugherty, Ph.D., our Chief Technology Officer. The loss of the services of any of our executive officers or key employees or consultants could materially and adversely affect our business. Our employment agreement with Mr. Walker expired on March 31, 2007; however, he has verbally agreed to continue to provide his services as needed and we are in the process of finalizing a new written employment agreement with him. We have no written agreement with Dr. Daugherty; however, he has verbally agreed to provide consulting services as needed.  We currently have no key man insurance for either Mr. Walker or Dr. Daugherty. Legislative and regulatory actions and potential new accounting pronouncements are likely to impact our future financial condition and results of operations. There have been certain regulatory changes, including the Sarbanes-Oxley Act of 2002, and there may potentially be new accounting pronouncements or additional regulatory changes which will have an impact on our future financial condition and results of operations. The Sarbanes-Oxley Act of 2002 and other rule changes as well as proposed legislative initiatives will increase our general and administrative costs, as we will incur increased legal and accounting fees to comply with such rule changes. In addition, proposed initiatives are expected to result in changes in certain accounting and disclosure rules. These and other potential changes could materially increase the expenses we report in our financial statements and adversely affect our operating results. We may be unable to compete effectively with other companies in our market sector, many of whom are substantially larger and more established and have significantly greater resources. We compete in two new, rapidly evolving and highly competitive market sectors: the microbattery market and the ultracapacitor market. We expect competition to persist and intensify in the future from a number of different sources. Increased competition could result in reduced prices and gross margins for our products and could require increased spending by us on research and development, sales and marketing and customer support, any of which could have a negative financial impact on our business. In the microbattery market, we compete with Energizer, Duracell and Rayovac, which sell batteries incorporating competing technologies. We also compete with several small companies that use competing technologies to manufacture thin film batteries. One of these competitors, Oak Ridge Micro-Energy, Inc. announced on March 14, 2008 that it now plans to license its technology, sell its research and development equipment and sublease its facility.  This is a strategy that would directly compete with us.  If Oak Ridge Micro-Energy, Inc. is able to capitalize on these opportunities, it could have a material adverse impact on our business.  We have also been informed that another competitor, Front Edge Technologies, Inc., is currently selling products for specialized government applications. We do not know the specific products or their sales prices, and so do not know whether our proposed products will be competitive with those sold by Front Edge Technologies, Inc.  22     There are other companies whom we know to be working on thin film batteries.  These companies include Ener1, Graphic Solutions, Inc., ITN Energy Systems, Solicore and Voltaflex.  In January 2008, Solicore announced a multi-year, multimillion unit agreement with Innovative Card Technologies, a smart card manufacturer.  If Solicore is able to deliver batteries that perform as well as or better than ours for the same or a lower price, it could have a material adverse impact on our business. Finally, Infinite Power Solutions, Inc., a licensee of Oak Ridge National Energy Lab, announced its plans to begin production of its thin film batteries in early 2008 and subsequently announced a strategic agreement with Lockheed Martin in October 2008. In the ultracapacitor market, we may compete with Maxwell Technologies, Panasonic, Epcos and Elna which (according to Frost & Sullivans World Capacitor Markets report, on pages 2-15, September 2005) together controlled over 80% of the world market share. We also may compete with many smaller companies that use competing technologies to manufacture ultracapacitors. If the sales prices of the ultracapacitors sold by these companies are lower than ours it could have a material adverse impact on our business. Many of our competitors are substantially larger than we are and have significantly greater financial, sales and marketing, technical, manufacturing and other resources and more established distribution channels. These competitors may be able to respond more rapidly to new or emerging technologies and changes in customer requirements or devote greater resources to the development, promotion and sale of their products than we can. We have encountered, and expect to encounter, customers who are extremely confident in and committed to the product offerings of our competitors. Furthermore, some of our competitors may make strategic acquisitions or establish cooperative relationships among themselves or with third parties to increase their ability to rapidly gain market share by addressing the needs of our prospective customers. These competitors may enter our existing or future markets with solutions that may be less expensive, provide higher performance or additional features or be introduced earlier than our solutions. Given the market opportunity in the low power battery and ultracapacitor markets, we also expect that other companies may enter our market with alternative products and technologies, which could reduce the sales or market acceptance of our products and services, perpetuate intense price competition or make our products obsolete. If any technology that is competing with ours is or becomes more reliable, higher performing, less expensive or has other advantages over our technology, then the demand for our products and services would decrease, which would harm our business. If we are unable to effectively manage our growth, we may experience operating inefficiencies and have difficulty meeting demand for our products. We anticipate that if we are able to raise sufficient capital, we will rapidly and significantly expand our operations. Our expansion plan calls for the hiring of two full time engineers to work on the development of our technology. We currently anticipate that further significant expansion will be required to address potential growth in our customer base and market opportunities. This expansion could place a significant strain on our management, products, development activities, sales and marketing personnel and other resources, which could harm our business. In the future, we may experience difficulties meeting the demand for our products. Our management team may not be able to achieve the rapid execution necessary to fully exploit the market for our products and services. We cannot assure you that our systems, procedures or controls will be adequate to support the anticipated growth in our operations. We may not be able to install management information and control systems in an efficient and timely manner, and our current or planned personnel, systems, procedures and controls may not be adequate to support our future operations.  23    Our limited ability to protect our intellectual property and defend against claims may adversely affect our ability to compete. We plan to rely on a combination of patent, copyright, trademark and trade secret laws and restrictions on disclosure to protect our intellectual property rights. However, we cannot assure you that the actions we have taken will adequately protect our intellectual property rights or that other parties will not independently develop similar or competing products that do not infringe on our patent pending. We enter into confidentiality or license agreements with our employees, consultants and corporate partners, and control access to and distribution of our documentation and other proprietary information. Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy or otherwise misappropriate or use our products or technology. Our industry is characterized by the existence of a large number of patents and frequent claims and related litigation regarding patent and other intellectual property rights. If we are found to infringe the proprietary rights of others, or if we otherwise settle such claims, we could be compelled to pay damages or royalties and either obtain a license to those intellectual property rights or alter our products so that they no longer infringe upon such proprietary rights. Any license could be very expensive to obtain or may not be available at all. Similarly, changing our products or processes to avoid infringing the rights of others may be costly or impractical. Litigation resulting from claims that we are infringing the proprietary rights of others could result in substantial costs and a diversion of resources, and could have a material adverse effect on our business, financial condition and results of operations. If we are unable to successfully protect our inventions through the issuance and enforcement of patents, our operating results could be adversely affected. We plan to have an active program to protect our proprietary technology through the filing of patents. To date, we have one patent pending and no issued patents. There can be no assurance that: · any current or future U.S. or foreign patent applications would be approved; · any issued patents will protect our intellectual property and not be challenged by third parties; · the validity of our patents will be upheld; · our patents will not be declared unenforceable; · the patents of others will not have an adverse effect on our ability to do business; or · others will not independently develop similar or competing technology or design around any patents that may be issued to us. If any of the above were to occur our operating results could be adversely affected. Our headquarters are located in Southern California where disasters may occur that could disrupt our operations and harm our business. Our corporate headquarters is located in Southern California. Historically, this region has been vulnerable to natural disasters and other risks, such as earthquakes, which at times have disrupted the local economy and posed physical risks to our property as well as that of our manufacturers. In addition, terrorist acts or acts of war targeted at the United States, and specifically Southern California, could cause damage or disruption to us, our employees, facilities, partners, suppliers, distributors and resellers, and customers, which could have a material adverse effect on our operations and financial results. We currently do not have redundant, multiple site capacity in the event of a natural disaster or catastrophic event. In the event of such an occurrence, our business would suffer.  24    Acquisitions may disrupt or otherwise have a negative impact on our business. In addition to our recent acquisition of a majority interest in SolRayo, we may acquire or make investments in complementary businesses, products, services or technologies on an opportunistic basis when we believe it will assist us in carrying out our business strategy. Growth through acquisitions has been a successful strategy used by other battery and electronic component companies.  We do not have any present understanding, nor are we having any discussions relating to any such acquisition or investment. In addition, we have no experience in identifying quality acquisition candidates, successfully acquiring them and integrating them into an existing infrastructure. If we buy a company, then we could have difficulty in assimilating that company's personnel and operations. In addition, the key personnel of the acquired company may decide not to work for us. An acquisition could distract our management and employees and increase our expenses. Furthermore, we may have to incur debt or issue equity securities to pay for any future acquisitions, the issuance of which could be dilutive to our existing stockholders. Anti-takeover provisions and our right to issue preferred stock could make a third-party acquisition of us, or the removal of our current management, difficult. We are a Delaware corporation. Anti-takeover provisions of Delaware law could make it more difficult for a third party to acquire control of us or remove members of current management, even if such change in control would be beneficial to stockholders. Our Certificate of Incorporation provides that our Board of Directors may issue preferred stock without stockholder approval. The issuance of preferred stock could make it more difficult for a third party to acquire us. All of the foregoing could adversely affect prevailing market prices for our common stock. Risks Related To Our Industry The markets in which we compete are subject to rapid technological progress and to compete we must continually introduce new products that achieve broad market acceptance. The low power battery and ultracapacitor markets are characterized by rapid technological progress, frequent new product introductions, changes in customer requirements and evolving industry standards. If we do not regularly introduce new products in these dynamic environments, our future product lines will become obsolete. Alternative technologies could achieve widespread market acceptance and displace the technologies on which we have based our future products. We cannot assure you that our technological approaches will achieve broad market acceptance or that other technologies or devices will not supplant our own products and technologies. In addition, nanowire-based microbattery technologies that are similar, but not identical, to ours have been developed at MIT and Stanford, with very good initial results.  These technologies might be closer to full commercialization than ours. Certain products from which we are excluded from pursuing may prove more lucrative than the products we may and do choose to pursue. We have entered into an exclusive license agreement with the University of Wisconsin that allows us to use patented ultracapacitor technology in all fields of use except automotive. This prohibited field of use may prove to be more lucrative than any permitted use we do pursue. Nanotechnology is a science in its infancy and there may be dangers involved in its use. Nanotechnology is defined in scientific circles by the use of materials less than 100 nanometers in size.  This is close to the dimensions of some molecules and atoms.  As this new branch of science progresses, we are finding out that, on the nanoscale, materials sometimes behave differently than they do on larger scales.  As a result, there is concern about health issues and toxicity.  Some nanoparticles have had unexpected effects, especially when used in medical experiments.  There is so little research done in this area to date that some have proposed a moratorium on selling nanotech-related products until the safety of such products can be fully assessed.  25    We have done no studies to determine the long term health effects of our products.  Although our products are not meant to be used in a human body, some issues could arise that might preclude us from using our product in certain markets. Risks Related To Our Common Stock We have no current plans to pay dividends. We have never paid cash dividends on our common stock and we do not expect to pay cash dividends on our common stock at any time in the foreseeable future. The future payment of dividends directly depends upon the future earnings, capital requirements, financial requirements and other factors that our Board of Directors will consider. Since we do not anticipate paying cash dividends on our common stock, the return on investment on our common stock will depend solely on an increase, if any, in the market value of the common stock. Our issuance of additional common stock in exchange for services or to repay debt would dilute the proportionate ownership and voting rights of our stockholders and could have a negative impact on the market price of our common stock. Our Board of Directors may generally issue shares of common stock to pay for debt or services, without further approval by our stockholders based upon such factors as our Board may deem relevant at that time.  During the six months ended September 30, 2008, and the year ended March 31, 2008, we issued a total of 996,000 shares and 5,099,641 shares, respectively, of our common stock in payment for services, including prepaid services.  It is likely that we will issue additional securities to pay for services and reduce debt in the future.  It is possible that we will issue additional shares of common stock under circumstances we may deem appropriate at the time. The elimination of monetary liability against our directors, officers and employees under our Certificate of Incorporation and the existence of indemnification rights for our directors, officers and employees may result in substantial expenditures by us and may discourage lawsuits against our directors, officers and employees. Our Certificate of Incorporation contains provisions which eliminate the liability of our directors for monetary damages to Enable IPC and our stockholders.  Our Bylaws also require us to indemnify our officers and directors.  We may also have contractual indemnification obligations under our agreements with our directors, officers and employees.  The foregoing indemnification obligations could cause us to incur substantial expenditures to cover the cost of settlement or damage awards against directors, officers and employees, which we may be unable to recoup.  These provisions and resultant costs may also discourage us from bringing a lawsuit against directors, officers and employees for breaches of their fiduciary duties, and may similarly discourage the filing of derivative litigation by our stockholders against our directors, officers and employees even though such actions, if successful, might otherwise benefit us and our stockholders. Our directors have the right to authorize the issuance of shares of our preferred stock and additional shares of our common stock. Our directors, within the limitations and restrictions contained in our Certificate of Incorporation and without further action by our stockholders, have the authority to issue shares of preferred stock from time to time in one or more series and to fix the number of shares and the relative rights, conversion rights, voting rights, and terms of redemption, liquidation preferences and any other preferences, special rights and qualifications of any such series.  We have no intention of issuing shares of preferred stock at the present time.  Any issuance of shares of preferred stock could adversely affect the rights of holders of our common stock. Should we issue additional shares of our common stock at a later time, each investors ownership interest in our stock would be proportionally reduced.  No investor will have any preemptive right to acquire additional shares of our common stock, or any of our other securities. If we fail to remain current on our reporting requirements, we could be removed from the OTC Bulletin Board, which would limit the ability of broker-dealers to sell our securities and the ability of stockholders to sell their securities in the secondary market.  26    Companies trading on the OTC Bulletin Board, such as Enable IPC, must be reporting issuers under Section 12 of the Exchange Act, and must be current in their reports under Section 13 of the Exchange Act, in order to maintain price quotation privileges on the OTC Bulletin Board.  If we fail to remain current on our reporting requirements, we could be removed from the OTC Bulletin Board.  As a result, the market liquidity for our securities could be adversely affected by limiting the ability of broker-dealers to sell our securities and the ability of stockholders to sell their securities in the secondary market. Our common stock is subject to the penny stock rules of the Securities and Exchange Commission, and the trading market in our common stock is limited, which makes transactions in our stock cumbersome and may reduce the investment value of our stock. Our common stock is penny stock because it is not registered on a national securities exchange or listed on an automated quotation system sponsored by a registered national securities association, pursuant to Rule 3a51-1(a) under the Exchange Act.  For any transaction involving a penny stock, unless exempt, the rules require: · That a broker or dealer approve a persons account for transactions in penny stocks; and · States that the broker or dealer receives from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased. The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the Securities and Exchange Commission relating to the penny stock market, which, in highlight form: · Sets forth the basis on which the broker or dealer made the suitability determination; and · That the broker or dealer received a signed, written agreement from the investor prior to the transaction. Generally, brokers may be less willing to execute transactions in securities subject to the penny stock rules.  This may make it more difficult for investors to dispose of our common stock and cause a decline in the market value of our stock. Disclosure also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the rights and remedies available to an investor in cases of fraud in penny stock transactions.  Finally, monthly statements have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks. The market for penny stocks has suffered in recent years from patterns of fraud and abuse. Stockholders should be aware that, according to SEC Release No. 34-29093, the market for penny stocks has suffered in recent years from patterns of fraud and abuse.  Such patterns include: · Control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; · Manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; · Boiler room practices involving high-pressure sales tactics and unrealistic price projections by inexperienced salespersons; · Excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and · The wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along with the resulting inevitable collapse of those prices and with consequential investor losses.  27    Our management is aware of the abuses that have occurred historically in the penny stock market.  Although we do not expect to be in a position to dictate the behavior of the market or of broker-dealers who participate in the market, management will strive within the confines of practical limitations to prevent the described patterns from being established with respect to our securities.  The occurrence of these patterns or practices could increase the volatility of our share price. ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds During August 2008, the Company issued an aggregate of 2,620,000 shares of common stock to seven investors for net proceeds of $111,000. Also during August, the Company issued 768,000 shares to an investor to satisfy a loan obligation totaling $30,725.  In addition, during August 2008 the Company issued an aggregate of 1,526,404 shares to four investors for services rendered; 1,065,404 of these were issued to three investors for accrued research and development services totaling $40,307 relating to the Companys ultracapacitor technology and the remaining 461,000 shares were issued for commissions on investments received and recorded as offering costs net of the investments received. ITEM 3. Defaults Upon Senior Securities Not applicable. ITEM 4. Submission of Matters to a Vote of Security Holders We held our annual meeting of stockholders at 29033 Avenue Sherman, Suite 202, Valencia, California 91355, on August 15, 2008, at 9:00 a.m. At the annual meeting, our stockholders were asked to vote on the following proposals: 1. Elect two members of our Board of Directors, each to serve on our Board until the 2011 annual meeting of stockholders or until his or her respective successor is duly elected and qualified; 2. Ratify the appointment of L.L. Bradford & Company, LLC as our independent auditors for the fiscal year ending March 31, 2009; and 3. Transact such other business as may properly come before the annual meeting and any adjournments or postponements. 20,507,803 of the 31,463,996 shares of issued and outstanding common stock were represented at the annual meeting. The proposals were voted on as follows: 1. Election of the following persons to our Board of Directors:  NomineeVotes ForVotes AgainstAbstentionsTimothy Lambirth, Esq.19,898,92400Philip Verges19,843,731055,192
  2. Proposal to appointment of L.L. Bradford & Company, LLC as our independent auditors for the fiscal year ending March 31, 2009: For: 19,898,424  Against: 500  Abstentions: 0  Broker Non-Votes: 0   28    ITEM 5. Other Information Not applicable. ITEM 6. Exhibits ExhibitNumberDescriptionLocation3.1Articles of IncorporationIncorporated by reference from the Registrants Form SB-2 Registration Statement filed on June 3, 2005 (Ex. No. 3.1)3.2Amended and Restated BylawsIncorporated by reference from the Registrants proxy statement filed on June 22, 20074.1Form of Subscription AgreementIncorporated by reference from the Registrants Form SB-2 Registration Statement filed on June 3, 2005 (Ex. No. 4.1)10.1Technology and Patent Assignment dated March 17, 2005, between the Registrant and Dr. Sung H. ChoiIncorporated by reference from the Registrants Form SB-2 Registration Statement filed on June 3, 2005 (Ex. No. 10.1)10.1(a)Amendment to Technology and Patent Assignment dated March 27, 2008, between the Registrant and Dr. Sung H. ChoiIncorporated by reference from the Registrants Annual Report on Form 10-KSB filed on June 30, 2008 (Ex. No. 10.1(a))10.2Standard Industrial/Commercial Multi-Tenant Lease - Gross, dated December 14, 2005, by and between the Registrant and Valencia AssociatesIncorporated by reference from the Registrants Form SB-2/A Registration Statement filed on January 24, 2006 (Ex. No. 10.7)10.3Lease, dated May 27, 2008. by and between the Registrant and Meadows Stabe Properties, LLCIncorporated by reference from the Registrants Annual Report on Form 10-KSB filed on June 30, 2008 (Ex. No. 10.3)10.4Employment Agreement, dated March 15, 2005, by and between the Registrant and David A. WalkerIncorporated by reference from the Registrants Form SB-2 Registration Statement filed on June 3, 2005 (Ex. No. 10.4)10.5Consulting Agreement, dated March 15, 2005, by and between the Registrant and Mark A. DaughertyIncorporated by reference from the Registrants Form SB-2 Registration Statement filed on June 3, 2005 (Ex. No. 10.5)10.6Consulting Agreement, dated March 15, 2005, by and between the Registrant and Dr. Sung H. ChoiIncorporated by reference from the Registrants Form SB-2 Registration Statement filed on June 3, 2005 (Ex. No. 10.6)10.7Enable IPC Corporation 2007 Stock Incentive PlanIncorporated by reference from the Registrants proxy statement filed on June 22, 200710.8Exclusive License Agreement, dated December 13, 2007, by and between the Registrant and Wisconsin Alumni Research FoundationIncorporated by reference from the Registrants Current Report on Form 8-K filed on December 19, 2007 (Ex. No. 10.1)10.9LLC Membership Purchase Agreement by and between the Registrant and SolRayo, LLC, effective October 1, 2008Filed herewith.
  29     14Code of EthicsIncorporated by reference from the Registrants Form SB-2 Registration Statement filed on June 3, 2005 (Ex. No. 14)31.1Rule 13a-14(a)/15d-14(a) Certifications of Principal Executive Officer and Principal Financial OfficerFiled herewith32.1Section 1350 Certifications of Principal Executive Officer and Principal Financial OfficerFiled herewith
    SIGNATURES  In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Dated: November 20, 2008  Enable IPC Corporation   By: /s/ David A. Walker____________________ David A. Walker Chief Executive Officer and Acting Chief Financial Officer (Principal Financial and Accounting Officer)  30    Exhibit 31.1 CERTIFICATION I, David A. Walker, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Enable IPC Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report; 4. As the registrant's sole certifying officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the small business issuer and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the small business issuer's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and 5. As the registrant's sole certifying officer, I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the small business issuer's auditors and the audit committee of the small business issuer's board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal control over financial reporting. Dated: November 20, 2008   /s/ David A. Walker________________________ David A. Walker Chief Executive Officer and acting Chief Financial Officer (Principal Executive Officer and Principal Financial and Accounting Officer)     Exhibit 32.1  WRITTEN STATEMENT OF THE PRINCIPAL EXECUTIVE OFFICER AND ACTING PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. 1350 Solely for the purposes of complying with 18 U.S.C. 1350, I, the undersigned Principal Executive Officer and acting Principal Financial Officer of Enable IPC Corporation (the "Company"), hereby certify, based on my knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2008 (the "Report") fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 20, 2008  /s/ David A. Walker____________________ David A. Walker Chief Executive Officer and acting Chief Financial Officer
(Principal Executive Officer and Principal Financial Officer)